World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
67
Citations
31182
World Ranking
2818
National Ranking
1307

Best Publications

  • Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

    Anthony Furlan;Randall Higashida;Lawrence Wechsler;Michael Gent

  • Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis

    Thomas G. Brott;Thomas G. Brott;Robert W. Hobson;George Howard;Gary S. Roubin

  • Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke

    Joseph P Broderick;Yuko Y Palesch;Andrew M Demchuk;Sharon D Yeatts

  • Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

    Wayne M. Clark;Stanley Wissman;Gregory W. Albers;Jack H. Jhamandas

  • Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

    W. N. Kernan;C. M. Viscoli;K. L. Furie;L. H. Young

  • Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study

    Gregory W. Albers;Vernice E. Bates;Wayne M. Clark;Rodney Bell

  • Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke Emergency Management of Stroke (EMS) Bridging Trial

    Christopher A. Lewandowski;Michael Frankel;Thomas A. Tomsick;Joseph Broderick

  • Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis

    Thomas G. Brott;George Howard;Gary S. Roubin;James F. Meschia

  • The rtPA (Alteplase) 0- to 6-Hour Acute Stroke Trial, Part A (A0276g) Results of a Double-Blind, Placebo-Controlled, Multicenter Study

    Wayne M. Clark;Gregory W. Albers;Kenneth P. Madden;Scott Hamilton

  • Oral Citicoline in Acute Ischemic Stroke An Individual Patient Data Pooling Analysis of Clinical Trials

    Antoni Dávalos;José Castillo;José Álvarez-Sabín;Julio J. Secades

  • Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial

    Michael D Hill;Renee H Martin;David Mikulis;John H Wong

  • Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    Bruce C V Campbell;Charles B L M Majoie;Gregory W Albers;Bijoy K Menon

  • Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

    Frank L. Silver;Ariane Mackey;Wayne M. Clark;William Brooks

  • Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.

    David C Hess;Lawrence R Wechsler;Wayne M Clark;Sean I Savitz

  • Monofilament intraluminal middle cerebral artery occlusion in the mouse.

    Wayne M. Clark;Nikola S. Lessov;Michael P. Dixon;Felix Eckenstein

  • A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients

    W. M. Clark;L. R. Wechsler;L. A. Sabounjian;U. E. Schwiderski

  • Interleukin-6 and interleukin-1 receptor antagonist in acute stroke.

    Nancy B. Beamer;Nancy B. Beamer;Bruce M. Coull;Bruce M. Coull;Wayne M. Clark;J. Samantha Hazel

  • A Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke

    Wayne M. Clark;Benjamin J. Williams;Kenneth A. Selzer;Richard M. Zweifler

  • Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.

    J Grotta;W Clark;B Coull;L C Pettigrew

  • A randomized dose-response trial of citicoline in acute ischemic stroke patients

    Wayne M. Clark;Steve Warach;L. C. Pettigrew;R. E. Gammans

  • Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule.

    Wayne M. Clark;Ken P. Madden;Robert Rothlein;Justin A. Zivin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Neuroscience in the USA opens doors to a range of connected fields and flexible online degrees. If you’re interested in applying your neuroscience background to mental health or behavioral sciences, you might consider pursuing one of the most affordable online psychology degree programs. These options offer a cost-effective path toward earning a degree that compliments neuroscience knowledge.

For those aiming for advanced or clinical practice, there are accelerated programs to explore. The 1 year online master's in social work can help you quickly prepare for a career in social services or counseling. Similarly, if you want to specialize in clinical psychology, the shortest online psyd programs can guide you toward practitioner roles in mental health care.

Another relevant option is marriage and family therapy. Obtaining credentials through an mft online degree provides training in supporting families and couples, which is a growing area of need. By exploring these pathways, neuroscience students can tailor their careers to diverse roles in research, therapy, and community support.

Best Scientists Citing Wayne M. Clark

Trending Scientists